225 related articles for article (PubMed ID: 33597092)
1. Socioeconomic inequality and omission of adjuvant radiation therapy in high-risk, early-stage endometrial cancer.
Luo LY; Aviki EM; Lee A; Kollmeier MA; Abu-Rustum NR; Tsai CJ; Alektiar KM
Gynecol Oncol; 2021 May; 161(2):463-469. PubMed ID: 33597092
[TBL] [Abstract][Full Text] [Related]
2. Disparities in adjuvant treatment of high-grade endometrial cancer in the Medicare population.
Corey L; Cote ML; Ruterbusch JJ; Vezina A; Winer I
Am J Obstet Gynecol; 2022 Apr; 226(4):541.e1-541.e13. PubMed ID: 34736911
[TBL] [Abstract][Full Text] [Related]
3. Disparities in receipt of care for high-grade endometrial cancer: A National Cancer Data Base analysis.
Bregar AJ; Alejandro Rauh-Hain J; Spencer R; Clemmer JT; Schorge JO; Rice LW; Del Carmen MG
Gynecol Oncol; 2017 Apr; 145(1):114-121. PubMed ID: 28159409
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant Therapy Use and Survival in Stage II Endometrial Cancer.
Lester-Coll NH; Young MR; Park HS; Ratner ES; Litkouhi B; Damast S
Int J Gynecol Cancer; 2017 Nov; 27(9):1904-1911. PubMed ID: 28763364
[TBL] [Abstract][Full Text] [Related]
5. Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study.
Felix AS; Cohn DE; Brasky TM; Zaino R; Park K; Mutch DG; Creasman WT; Thaker PH; Walker JL; Moore RG; Lele SB; Guntupalli SR; Downs LS; Nagel CI; Boggess JF; Pearl ML; Ioffe OB; Randall ME; Brinton LA
Am J Obstet Gynecol; 2018 Nov; 219(5):459.e1-459.e11. PubMed ID: 30096321
[TBL] [Abstract][Full Text] [Related]
6. Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment.
Kaspers M; Llamocca E; Quick A; Dholakia J; Salani R; Felix AS
Am J Obstet Gynecol; 2020 Sep; 223(3):398.e1-398.e18. PubMed ID: 32142825
[TBL] [Abstract][Full Text] [Related]
7. Factors Predictive of Receiving Adjuvant Radiotherapy in High-Intermediate-Risk Stage I Endometrial Cancer.
McGunigal M; Pollock A; Doucette JT; Liu J; Chadha M; Kalir T; Gupta V
Int J Gynecol Cancer; 2018 Jun; 28(5):882-889. PubMed ID: 29538253
[TBL] [Abstract][Full Text] [Related]
8. Utilization of adjuvant therapies and their impact on survival for women with stage IIIC endometrial adenocarcinoma.
Wong AT; Rineer J; Lee YC; Schwartz D; Safdieh J; Weiner J; Choi K; Schreiber D
Gynecol Oncol; 2016 Sep; 142(3):514-9. PubMed ID: 27421751
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant radiation therapy is associated with improved overall survival in high-intermediate risk stage I endometrial cancer: A national cancer data base analysis.
Gupta V; McGunigal M; Prasad-Hayes M; Kalir T; Liu J
Gynecol Oncol; 2017 Jan; 144(1):119-124. PubMed ID: 27793358
[TBL] [Abstract][Full Text] [Related]
10. Patient characteristics and health system factors associated with adjuvant radiation therapy receipt in older women with early-stage endometrial cancer.
Park J; Lund JL; Kent EE; Anderson C; Brewster WR; Olshan AF; Nichols HB
J Geriatr Oncol; 2023 Jan; 14(1):101371. PubMed ID: 36088216
[TBL] [Abstract][Full Text] [Related]
11. Impact of CALGB 9343 Trial and Sociodemographic Variation on Patterns of Adjuvant Radiation Therapy Practice for Elderly Women (≥70 Years) with Stage I, Estrogen Receptor-positive Breast Cancer: Analysis of the National Cancer Data Base.
Chu QD; Zhou M; Medeiros KL; Peddi P; Wu XC
Anticancer Res; 2017 Oct; 37(10):5585-5594. PubMed ID: 28982874
[TBL] [Abstract][Full Text] [Related]
12. Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma.
Lee CM; Szabo A; Shrieve DC; Macdonald OK; Gaffney DK
JAMA; 2006 Jan; 295(4):389-97. PubMed ID: 16434629
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant Chemotherapy versus Radiotherapy in High-risk, Early-stage Endometrioid Endometrial Carcinoma.
Wu M; Yang YN; Huang YH; Cai J; He XQ; Wang ZH
Curr Med Sci; 2022 Feb; 42(1):185-191. PubMed ID: 34669113
[TBL] [Abstract][Full Text] [Related]
14. Racial disparities in young women with endometrial cancer.
Mukerji B; Baptiste C; Chen L; Tergas AI; Hou JY; Ananth CV; Neugut AI; Hershman DL; Wright JD
Gynecol Oncol; 2018 Mar; 148(3):527-534. PubMed ID: 29307452
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant treatment and outcomes for patients with stage IIIA grade 1 endometrioid endometrial cancer.
Montes de Oca MK; Albright BB; Secord AA; Havrilesky LJ; Moss HA
Int J Gynecol Cancer; 2021 Dec; 31(12):1549-1556. PubMed ID: 34725205
[TBL] [Abstract][Full Text] [Related]
16. Disparities in care for elderly women with endometrial cancer adversely effects survival.
Torgeson A; Boothe D; Poppe MM; Suneja G; Gaffney DK
Gynecol Oncol; 2017 Nov; 147(2):320-328. PubMed ID: 28802765
[TBL] [Abstract][Full Text] [Related]
17. The impact of race, comorbid conditions and obesity on survival endpoints in women with high grade endometrial carcinoma.
Fucinari J; Elshaikh MA; Ruterbusch JJ; Khalil R; Dyson G; Shultz D; Ali-Fehmi R; Cote ML
Gynecol Oncol; 2021 Jul; 162(1):134-141. PubMed ID: 33985795
[TBL] [Abstract][Full Text] [Related]
18. Patterns of adjuvant radiation usage and survival outcomes for stage I endometrial carcinoma in a large hospital-based cohort.
Wong AT; Rineer J; Schwartz D; Weiner J; Safdieh J; Choi K; Schreiber D
Gynecol Oncol; 2017 Jan; 144(1):113-118. PubMed ID: 27823769
[TBL] [Abstract][Full Text] [Related]
19. More than treatment refusal: a National Cancer Database analysis of adjuvant treatment refusal and racial survival disparities among women with endometrial cancer.
Barrington DA; Sinnott JA; Nixon D; Padamsee TJ; Cohn DE; Doll KM; Donneyong MM; Felix AS
Am J Obstet Gynecol; 2022 Aug; 227(2):244.e1-244.e17. PubMed ID: 35283091
[TBL] [Abstract][Full Text] [Related]
20. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
